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MicroarrayTranscriptomic studies revealed that hundreds of mRNAs show differential expression in the brains of sleeping
relative to awake rats, mice, ﬂies, and sparrows. Although these results have offered clues regarding the molec-
ular consequences of sleep and sleep loss, their functional signiﬁcance thus far has been limited. This is probably
because the previous studies pooled transcripts from all brain cells, including neurons and glia. In Bellesi et al.
(2015) [1], we used the translating ribosome afﬁnity puriﬁcation technology (TRAP) and microarray analysis
to obtain a genome-widemRNAproﬁling of astrocytes as a function of sleep andwake.We used bacterial artiﬁcial
chromosome (BAC) transgenic mice expressing eGFP tagged ribosomal protein L10a under the promoter of the
Aldh1L1 gene, a highly expressed astrocytic gene. Using this approach, we could extract only the astrocytic
mRNAs, and only those already committed to be translated into proteins (L10a is part of the translational
machinery).
Here, we report a detailed description of the protocol used in the study (Bellesi et al., 2015 [1]). Array data have
been submitted to NCBI GEO under accession number (GSE69079).
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationsrganism/cell
line/tissueAdult heterozygous Aldh1L1–eGFP-L10a micex Either sex
quencer or
array typeAffymetrix GeneChip Mouse Genome 430 2.0 arraysata format Raw data: cell ﬁles; Normalized data: xls ﬁle
xperimental
factorsSleep, spontaneous wake, 4 h sleep deprivationxperimental
featuresMicroarray dataset of the effects of sleep and wake on
astrocytic gene expressiononsent All animal procedures followed the National Institutes of
Health Guide for the Care and Use of Laboratory Animals and
facilities were reviewed and approved by the IACUC of the
University of Wisconsin-Madisonmple source
locationMadison, WI, US1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE69079.. This is an open access article under2. Experimental design, materials and methods
2.1. Experimental design
Three groups of adult heterozygous Aldh1L1–eGFP-L10a mice were
used (n = 6/group): awake mice (W) were collected during the dark
phase (~3–5 am) at the end of a long period of wake (N1 h, interrupted
by periods of sleep of b5min), and after spending at least 70% of thepre-
vious 6–7 h awake. Sleepingmice (S)were collected during the light pe-
riod (~3–5 pm), at the end of a long period of sleep (N45 min,
interrupted by periods of wake of b4 min), and after spending at least
75% of the previous 6–7 h asleep. Sleep deprived mice (SD) were spon-
taneously awake during most of the dark phase and then kept awake
during the ﬁrst 4 h of the light period by exposure to novel objects.
2.2. Video monitoring of sleep and wake
To avoid risks of tissue damage and inﬂammation due to the implant
of EEG electrodes, video recordings were performed continuously with
infrared cameras and used to determine the behavioral state of mice
used in the study. We previously demonstrated that video-monitoring
consistently estimates total sleep timewith ~90% accuracy [2], although
it cannot distinguish NREM sleep from REM sleep. Motor activity was
quantiﬁed by custom-made video-based motion detection algorithms
with a time resolution of 1 s. The program detects animal motion
every second within a previously set monitored area corresponding tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. a. Summary scheme of the TRAPmethod. b. Representative puriﬁcation of 18S and 28S rRNA fromAldh1L1–eGFPL10a transgenicmice (green) as detected by Bioanalyzer PicoChips
(Agilent Technologies). Note that the puriﬁcation did not occur in a wild type littermate used as a control (blue).
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changed over time. Speciﬁcally, it compares the last current image
with the previous one and assigns a value in percent of changes in num-
ber of pixels occurring every second. These values and the relative time
are then saved in a txt report ﬁle and subsequently analyzed with
custom-made Matlab scripts (MATLAB and Statistics Toolbox Release
2015a, The MathWorks, Inc., Natick, Massachusetts, United States) [3].
2.3. Antibody preparation
To prepare antibody-bound beads Streptavidin MyOne T1
Dynabeads (Invitrogen) were incubated with biotinylated Protein L
(Fisher Pierce) for 35 min at RT in PBS 0.1 M using gentle end-over-
end rotation. Then, protein L-coated beads were collected on the
DynaMag-2 magnet (Invitrogen) and washed ﬁve times with PBS
0.1 M containing 3% (w/v) IgG and Protease-free BSA (Jackson
ImmunoResearch). Antibody binding was carried out in 0.15 M KCl
buffer (20 mM Hepes–KOH, 5 mM MgCl2, 150 mM KCl, 1% NP-40,
0.5 mM DTT, and 100 μg/ml Cycloheximide) for 1 h at room tempera-
ture using gentle end-over-end rotation with 50 μg each of two mono-
clonal anti-GFP antibodies (19C8 and 19F7, Memorial Sloan-Kettering
Cancer Center Monoclonal Antibody Core Facility). After antibody bind-
ing, beads were washed and resuspended in 0.15 M KCl buffer.
2.4. Tissue collection, translating ribosome afﬁnity puriﬁcation and RNA
extraction
The TRAP protocol has been developed by [4,5] and it has been also
previously described in [6]. Under anesthesia S, SD andWmice (n= 6/
group) were decapitated and the forebrain regions (striatum and cere-
bral cortex) were quickly dissected. Tissue was placed in 2 ml of chilled
Lysis Buffer (20 mM Hepes KOH, 5 mM MgCl2, 150 mM KCl, 0.5 mM
DTT, 100 μg/ml Cycloheximide, protease inhibitors, 20 μl Rnasin, 20 μl
Superasin) and homogenized with a Teﬂon-Glass homogenizer. Ho-
mogenateswere then centrifuged at 4 °C for 10min at 2000×g to obtain
a post-nuclear supernatant. NP-40 (1% ﬁnal) and DHPC (30 mM ﬁnal)
were added to the supernatant, mixed by gentle inversion and incu-
bated on ice for 5 min. Next, samples were again centrifuged at 4 °C
for 10 min at 20,000 ×g to obtain a post-mitochondrial supernatant.
This fractionwas combinedwith the GFP antibody-coated beads and in-
cubated o/nwith gentle end-over-end rotation at 4 °C. Beads were then
collectedwith themagnet andwashed four times in high-salt polysome
wash buffer (20mMHepes–KOH, 5 mMMgCl2, 350mMKCl, 1% NP-40,
0.5 mM DTT, and 100 μg/ml Cycloheximide). After washes, beads werecollected, resuspended and vortexed in 100 μl Lysis Buffer with ß-
Mercaptoethanol from the Absolutely RNA Nanoprep kit (Agilent) and
incubated for 10 min at RT. As illustrated in Fig. 1a, the RNA was ex-
tracted from both the immunoprecipitated (IP) and the supernatant
(unbound fraction; UB) fractions. The IP RNA, which represents the
mRNA immunoprecipitated from the astrocytes, was separated from
the beads with the magnet and puriﬁed following the Nanoprep proto-
col, while the UB RNA, which represents themRNA of the remaining not
precipitated cells, was isolated using the RNeasy Mini kit (Qiagen). Fi-
nally, RNA levels in IP and UB samples were assessed by a Qubit Fluo-
rometer (Invitrogen) with the Quant-iT RNA assay kit (Invitrogen,
Q32852) and the quality of the RNA was assessed using the Agilent
2100 Bioanalyzer (Agilent) (see Fig. 1b for a representative example).2.5. Microarray: labeling, hybridization and data analysis
For IP and UB samples (6 IP and 2 UB for each of the 3 experimental
groups, S, SD,W), 5 ngof puriﬁedmRNAwas ampliﬁedwith theOvation
PicoWTA system (NuGen, #3300). Five micrograms of ampliﬁed mate-
rial was then fragmented, biotin labeled with the Encore Biotin Module
(NuGen, #4200), hybridized to Affymetrix GeneChip Mouse Genome
430 2.0 arrays (n=24, one chip per sample) following Affymetrix stan-
dard protocol, and scanned using the GC3000 7G scanner (Affymetrix).
Array data analysis was performed using the Bioconductor Limma pack-
age [7]. For both IP and UB replicates, GeneChip Cel ﬁles were imported
into Bioconductor, data were converted to log2 scale, and normalized
within each behavioral state group using Robust Multi-array Average
(RMA) [8] implemented in the Bioconductor package affy (Fig. 2).
To obtain a measure of the enrichment, the expression intensity of
each IP probeset was compared against its UB expression using the
Welch's t-test with Benjamini and Hochberg FDR multiple test correc-
tion. Probesets with IP/UB ratio N 2 and p b 0.01 were considered
enriched, while probesets with IP/UB ratio b 2 and p b 0.01were consid-
ered depleted. Finally, to independently verify the validity of the TRAP
method, IP/UB ratios for 200 “top” genes previously found to be
enriched in astrocytes, oligodendrocytes, and neurons [8]were calculated
(Fig. 3).Acknowledgments
This work was supported by National Institutes of Health (NIH)
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Fig. 2. Distribution of probeset intensities for S, W, SD IP samples (ﬁrst three rows; letters (a–f) indicate single mice) and for UB samples (last raw) before and after RMA normalization.
Fig. 3. Scatter plots shownormalizedmean expression values for IP (x-axis, n=18, 6/group) andUB (y-axis, n=6, 2/group) samples of S,Wand SDgroups. Themiddle diagonal black line
indicates equal expression. In all three experimental groups, the top 200 genes identiﬁed by [8] as speciﬁc for astrocytes (red) are enriched in IP samples, whereas most of the top 200
genes speciﬁc for oligodendrocytes (yellow) and neurons (blue) are enriched in S, W and SD UB samples.
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